Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 17;68(10):1605–1619. doi: 10.1007/s00262-019-02396-8

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 4 — Effect of MA and LAM treatment on MDDCs. a Percentage of CD141⁺ CD11c⁺ cells among CD1a⁺ viable cells stimulated with MA and/or LAM from Aoyama B isolates was measured by flow cytometry. Data are shown as the mean ± SD of n = 3 samples per measurement. b The percentage of XCR1⁺CD141⁺ cells stimulated with MA and/or LAM from Aoyama B isolates was measured. Data are shown as the mean ± SD of n = 4 samples per measurement. c Expression of co-stimulatory molecules on MDDCs stimulated with MA and/or LAM from Aoyama B isolates. Data are shown as the mean ± SD of n = 3 samples per measurement. d IL-10 and IL-12p40 production of MDDCs stimulated with MA and/or LAM from Aoyama B isolate in supernatant. Data are shown as the mean ± SD of n = 4 samples per measurement. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; one-way ANOVA followed by Bonferroni post-tests